QIAGEN collaborates with McGill University to advance microbiome research

15-Nov-2024 - QIAGEN announced a collaboration with the McGill University Centre for Microbiome Research to support microbiome research activities and outcomes. The three-year partnership will further drive microbiome sciences – the study of a community of microorganisms that can be found living together in ...

Collaboration between medac and start-up chiron to develop organ-on-chip technology

Further development and establishment of animal free testing methods for the pharmaceutical industry

12-Nov-2024 - Testing new substances in animals is a regulatory cornerstone of drug development. At the same time, the development of animal free testing methods is progressing. In this context the pharmaceutical company medac and the start-up chiron biotechnology are working together on the further ...

Ardena Expands Bioanalytical Services in Europe

01-Nov-2024 - Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, announced a substantial expansion of its Bioanalytical Services in the Netherlands. This strategic investment includes establishing a ...

Revealing DNA behavior in record time

26-Aug-2024 - “DNA, RNA and proteins are the key players to regulate all processes in the cells of our body,” Leiden Professor John van Noort explains. “To understand the (mis-)functioning of these molecules, it is essential to uncover how their 3D structure depends on their sequence and for this it is ...

UMC Utrecht and VectorY Therapeutics collaborate in ALS Biomarker Study

Finding these biomarkers is expected to help diagnose ALS and monitor disease progression and improve the design of future clinical studie

18-Jun-2024 - UMC Utrecht has enrolled its first patient for a new study to identify biomarkers of Amyotrophic Lateral Sclerosis (ALS). The observational investigator-initiated study is led by Professor Dr. Leonard van den Berg and supported by VectorY Therapeutics. VectorY Therapeutics is developing ...

Fungus breaks down ocean plastic

“What makes this research scientifically outstanding, is that we can quantify the degradation process”

17-Jun-2024 - A fungus living in the sea can break down the plastic polyethylene, provided it has first been exposed to UV radiation from sunlight. Researchers from, among others, NIOZ published their results in the scientific journal Science of the Total Environment. They expect that many more plastic ...

Portable AI-based test kit to identify bacterial infections

Dutch scientist selected as a finalist for the Young Inventors Prize 2024: Her startup focuses on the most common types of infection

11-Jun-2024 - According to a study published in The Lancet, one in eight global deaths in 2019 was caused by common bacterial infections, which are the second leading cause of death worldwide. Due to slow or ineffective diagnostics many treatments are carried out with limited information on the condition, ...

Cloud-based platform for analyzing cryo-EM data secures pre-seed investment

Dutch biotech start-up aims to accelerate the development of new active ingredients

04-Mar-2024 - CryoCloud, a biotech start-up based in Utrecht in the Netherlands, recently closed a financing round of 500,000 euros. The company has thus reached an important milestone on its way to optimizing cryo-electron microscopy (cryo-EM). CryoCloud was founded in 2021 by Munich-based Robert Englmeier, ...

Fermentation revolution?

Trash becomes treasure as bio-waste yields valuable acetone and isopropanol

07-Feb-2024 - In a major stride towards sustainable industrial fermentation, a team of researchers at Delft University of Technology (TU Delft) in The Netherlands, has unveiled pioneering advancements in the purification of isopropanol and acetone from the fermentation of waste gases. The study, published in ...

Onera raises over €30M in Series C funding

26-Jan-2024 - Onera Health announced the completion of its Series C financing round. This latest funding round brings Onera’s total investment to date to more than €55 million. The round was led by new investor EQT Life Sciences, investing from its EQT Health Economics 3 fund, co-led by new investor Gimv, and ...